Boehringer Ingelheim Venture Fund


Germany

Homepage

Boehringer Ingelheim Venture Fund

12.11.2018 10:05

AMAL Therapeutics finalises CHF 33 million Series B round

Please login or
register to use the
bookmark feature
05.09.2017 11:45

AMAL Therapeutics raises CHF 8.8 million in Series B round

Please login or
register to use the
bookmark feature
03.11.2016 12:10

NBE Therapeutics Raises CHF 20 Million in Series B Funding

Please login or
register to use the
bookmark feature
30.03.2016 09:24

Amal Therapeutics raises CHF 3 million in a Series A financing round

Please login or
register to use the
bookmark feature

By continuing to use this website you agree with our TERMS AND CONDITIONS